Tellgen Corporation
SHZ: 300642.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jian Er Yao
- Employees
- 522
- Headquarters
- Shanghai, China
- IPO year
- 2017
- Market cap
- CN¥2.7B
- Website
- https://www.tellgen.com
Loading 300642…
Loading profile data…Frequently asked questions about 300642
What does Tellgen Corporation (300642.SZ) do?
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.
Where does 300642.SZ trade?
Tellgen Corporation (300642.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300642.SZ in?
Tellgen Corporation (300642.SZ) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Tellgen Corporation?
Jian Er Yao is the chief executive officer of Tellgen Corporation (300642.SZ).
Where is Tellgen Corporation headquartered?
Tellgen Corporation is headquartered in China.
Does 300642.SZ pay a dividend?
Yes — Tellgen Corporation (300642.SZ) paid a trailing twelve-month dividend of CNY 0.15 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300642.SZ go public?
Tellgen Corporation (300642.SZ) completed its initial public offering in 2017.